Consainsights logo
Reports / Biosimilar Testing and Development Services Market

Biosimilar Testing and Development Services Market

Biosimilar Testing and Development Services Market Research Report – Segmented By Clinical Assays (NAB ASSAYS, PK ASSAYS, TIERED IMMUNOGENICITY TESTING), Comparability Testing (ADCC AND CDC ASSAYS CELL BASED ASSAYS, C1Q BINDING BY ELISA, EFFECTOR BINDING BIACORE, KINETIC BINDING ASSAYS BY BIACORE), Region (ASIA-PACIFIC, EUROPE, LAMEA) & Region (North America, Europe, APAC, Latin America, Middle East and Africa) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2017 to 2026.


01

Executive Summary

Biosimilar Testing and Development Services Market was valued at US $21.10 billion in 2021 and is projected to grow at 17.21% CAGR over the forecast period to reach US $54.71 billion by 2027. Biosimilar Testing and Development Services Market represented US $5.74 billion opportunity over 2019-2021 and estimated to create US $33.61 billion opportunity in 2027 over 2021.

Biosimilar Testing and Development Services from Consainsights analyses the Biosimilar Testing and Development Services Market in the Life Sciences industry over the forecast period to 2027.

Biosimilar Testing and Development Services research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Biosimilar Testing and Development Services segmentation includes Clinical Assays, Comparability Testing, Region and Geography.

Based on the Clinical Assays, the Biosimilar Testing and Development Services analysis covers PK ASSAYS, TIERED IMMUNOGENICITY TESTING, NAB ASSAYS.

In Clinical Assays segment, PK ASSAYS segment has highest cagr growth of 15.16%.

Based on the Comparability Testing, the Biosimilar Testing and Development Services analysis covers EFFECTOR BINDING BIACORE, C1Q BINDING BY ELISA, KINETIC BINDING ASSAYS BY BIACORE, ADCC AND CDC ASSAYS CELL BASED ASSAYS.

In Comparability Testing segment, EFFECTOR BINDING BIACORE segment has highest cagr growth of 15.16%.

Based on the Region, the Biosimilar Testing and Development Services analysis covers EUROPE, ASIA-PACIFIC, LAMEA.

In Region segment, EUROPE segment has highest cagr growth of 15.16%.

Based on the region, the Biosimilar Testing and Development Services analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include EUROFINS SCIENTIFIC, SGS SA, CHARLES RIVER LABORATORIES INTERNATIONAL INC., PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC., EXOVA GROUP PLC., SOURCE BIOSCIENCE PLC., INTERTEK GROUP PLC., MEDISTRI SA, PACE ANALYTICAL SERVICES INC., SIGMA-ALDRICH CO. LLC and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

  • Revenue Share (%), By Clinical Assays (2021)
    Revenue Share (%), By Clinical Assays (2021)
  • Revenue Share (%), By Comparability Testing (2021)
    Revenue Share (%), By Comparability Testing (2021)
  • Revenue Share (%), By Region (2021)
    Revenue Share (%), By Region (2021)
02

Market Overview

  • The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
  • The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
  • The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
  • Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
  • Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
  • As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.
  • The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
  • For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
  • For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.
03

By Clinical Assays

  • PK ASSAYS accounted for US$12.48 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • TIERED IMMUNOGENICITY TESTING accounted for US$5.35 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • NAB ASSAYS accounted for US$3.27 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Biosimilar Testing and Development Services Market Y-o-Y Growth (USD billion), By Clinical Assays 2019 - 2027
Biosimilar Testing and Development Services Market Y-o-Y Growth (USD billion), By Clinical Assays 2019 - 2027
Biosimilar Testing and Development Services Market Size, By Clinical Assays, 2019-2027 (USD billion)
Biosimilar Testing and Development Services Market Size, By Clinical Assays, 2019-2027 (USD billion)

The NAB ASSAYS segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

NAB ASSAYS: global Biosimilar Testing and Development Services Market Revenue Opportunity (Us$ Mn)
NAB ASSAYS: global Biosimilar Testing and Development Services Market Revenue Opportunity (Us$ Mn)

The PK ASSAYS segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

PK ASSAYS: global Biosimilar Testing and Development Services Market Revenue Opportunity (Us$ Mn)
PK ASSAYS: global Biosimilar Testing and Development Services Market Revenue Opportunity (Us$ Mn)

The TIERED IMMUNOGENICITY TESTING segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

TIERED IMMUNOGENICITY TESTING: global Biosimilar Testing and Development Services Market Revenue Opportunity (Us$ Mn)
TIERED IMMUNOGENICITY TESTING: global Biosimilar Testing and Development Services Market Revenue Opportunity (Us$ Mn)
04

By Comparability Testing

  • EFFECTOR BINDING BIACORE accounted for US$10.52 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • C1Q BINDING BY ELISA accounted for US$4.34 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • KINETIC BINDING ASSAYS BY BIACORE accounted for US$3.66 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • ADCC AND CDC ASSAYS CELL BASED ASSAYS accounted for US$2.58 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Biosimilar Testing and Development Services Market Y-o-Y Growth (USD billion), By Comparability Testing 2019 - 2027
Biosimilar Testing and Development Services Market Y-o-Y Growth (USD billion), By Comparability Testing 2019 - 2027
Biosimilar Testing and Development Services Market Size, By Comparability Testing, 2019-2027 (USD billion)
Biosimilar Testing and Development Services Market Size, By Comparability Testing, 2019-2027 (USD billion)

The ADCC AND CDC ASSAYS CELL BASED ASSAYS segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

ADCC AND CDC ASSAYS CELL BASED ASSAYS: global Biosimilar Testing and Development Services Market Revenue Opportunity (Us$ Mn)
ADCC AND CDC ASSAYS CELL BASED ASSAYS: global Biosimilar Testing and Development Services Market Revenue Opportunity (Us$ Mn)

The C1Q BINDING BY ELISA segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

C1Q BINDING BY ELISA: global Biosimilar Testing and Development Services Market Revenue Opportunity (Us$ Mn)
C1Q BINDING BY ELISA: global Biosimilar Testing and Development Services Market Revenue Opportunity (Us$ Mn)

The EFFECTOR BINDING BIACORE segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

EFFECTOR BINDING BIACORE: global Biosimilar Testing and Development Services Market Revenue Opportunity (Us$ Mn)
EFFECTOR BINDING BIACORE: global Biosimilar Testing and Development Services Market Revenue Opportunity (Us$ Mn)

The KINETIC BINDING ASSAYS BY BIACORE segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

KINETIC BINDING ASSAYS BY BIACORE: global Biosimilar Testing and Development Services Market Revenue Opportunity (Us$ Mn)
KINETIC BINDING ASSAYS BY BIACORE: global Biosimilar Testing and Development Services Market Revenue Opportunity (Us$ Mn)
05

By Region

  • EUROPE accounted for US$12.20 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • ASIA-PACIFIC accounted for US$5.12 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • LAMEA accounted for US$3.78 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Biosimilar Testing and Development Services Market Y-o-Y Growth (USD billion), By Region 2019 - 2027
Biosimilar Testing and Development Services Market Y-o-Y Growth (USD billion), By Region 2019 - 2027
Biosimilar Testing and Development Services Market Size, By Region, 2019-2027 (USD billion)
Biosimilar Testing and Development Services Market Size, By Region, 2019-2027 (USD billion)

The ASIA-PACIFIC segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

ASIA-PACIFIC: global Biosimilar Testing and Development Services Market Revenue Opportunity (Us$ Mn)
ASIA-PACIFIC: global Biosimilar Testing and Development Services Market Revenue Opportunity (Us$ Mn)

The EUROPE segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

EUROPE: global Biosimilar Testing and Development Services Market Revenue Opportunity (Us$ Mn)
EUROPE: global Biosimilar Testing and Development Services Market Revenue Opportunity (Us$ Mn)

The LAMEA segment market was valued at US$ XX Mn in 2019 and grown at XX% CAGR over the historic years (2019 - 2027) to reach US$ XX Mn and is projected to grow at XX% CAGR over the forecast period to reach US$ XX Mn by 2027. The market represented the US$ XX Mn opportunity over 2019 - 2027 and estimated to create US$ XX Mn opportunity over 2019 - 2027.

LAMEA: global Biosimilar Testing and Development Services Market Revenue Opportunity (Us$ Mn)
LAMEA: global Biosimilar Testing and Development Services Market Revenue Opportunity (Us$ Mn)
06

North America

  • In 2021, North America segment accounted for US$21.10 Bn and is expected grow with a CAGR of 17.21% over the forecast years.
  • In North America, United States accounted for US$10.82 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Canada accounted for US$10.28 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
North America Biosimilar Testing and Development Services Market, By Country, 2019-2027 (USD billion)
North America Biosimilar Testing and Development Services Market, By Country, 2019-2027 (USD billion)
North America Biosimilar Testing and Development Services Market - Market Opportunity (USD billion), 2019, 2021 & 2027
North America Biosimilar Testing and Development Services Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Revenue Share (%), By Clinical Assays - North America (2021)
Revenue Share (%), By Clinical Assays - North America (2021)
Revenue Share (%), By Comparability Testing - North America (2021)
Revenue Share (%), By Comparability Testing - North America (2021)
Revenue Share (%), By Region - North America (2021)
Revenue Share (%), By Region - North America (2021)
North America Biosimilar Testing and Development Services Market, By Country, 2019-2027 (USD billion)
North America Biosimilar Testing and Development Services Market, By Country, 2019-2027 (USD billion)
United States Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
United States Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
United States Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
United States Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Canada Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Canada Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Canada Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Canada Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
07

Europe

  • In 2021, Europe segment accounted for US$21.10 Bn and is expected grow with a CAGR of 17.21% over the forecast years.
  • In Europe, Germany accounted for US$8.69 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • United Kingdom accounted for US$4.94 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • France accounted for US$3.33 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Spain accounted for US$2.11 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Russia accounted for US$0.87 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Italy accounted for US$0.64 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Europe accounted for US$0.52 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Europe Biosimilar Testing and Development Services Market, By Country, 2019-2027 (USD billion)
Europe Biosimilar Testing and Development Services Market, By Country, 2019-2027 (USD billion)
Europe Biosimilar Testing and Development Services Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Europe Biosimilar Testing and Development Services Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Revenue Share (%), By Clinical Assays - Europe (2021)
Revenue Share (%), By Clinical Assays - Europe (2021)
Revenue Share (%), By Comparability Testing - Europe (2021)
Revenue Share (%), By Comparability Testing - Europe (2021)
Revenue Share (%), By Region - Europe (2021)
Revenue Share (%), By Region - Europe (2021)
Europe Biosimilar Testing and Development Services Market, By Country, 2019-2027 (USD billion)
Europe Biosimilar Testing and Development Services Market, By Country, 2019-2027 (USD billion)
Germany Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Germany Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Germany Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Germany Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
United Kingdom Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
United Kingdom Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
United Kingdom Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
United Kingdom Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
France Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
France Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
France Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
France Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Spain Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Spain Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Spain Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Spain Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Russia Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Russia Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Russia Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Russia Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Italy Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Italy Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Italy Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Italy Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Rest of Europe Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Rest of Europe Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Rest of Europe Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Rest of Europe Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
08

Asia-Pacific

  • In 2021, Asia-Pacific segment accounted for US$21.10 Bn and is expected grow with a CAGR of 17.21% over the forecast years.
  • In Asia-Pacific, China accounted for US$8.81 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Japan accounted for US$5.28 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • India accounted for US$3.21 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Southeast Asia accounted for US$1.55 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Australia & New Zealand accounted for US$1.79 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Asia-Pacific accounted for US$0.45 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Asia-Pacific Biosimilar Testing and Development Services Market, By Country, 2019-2027 (USD billion)
Asia-Pacific Biosimilar Testing and Development Services Market, By Country, 2019-2027 (USD billion)
Asia-Pacific Biosimilar Testing and Development Services Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Asia-Pacific Biosimilar Testing and Development Services Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Revenue Share (%), By Clinical Assays - Asia-Pacific (2021)
Revenue Share (%), By Clinical Assays - Asia-Pacific (2021)
Revenue Share (%), By Comparability Testing - Asia-Pacific (2021)
Revenue Share (%), By Comparability Testing - Asia-Pacific (2021)
Revenue Share (%), By Region - Asia-Pacific (2021)
Revenue Share (%), By Region - Asia-Pacific (2021)
Asia-Pacific Biosimilar Testing and Development Services Market, By Country, 2019-2027 (USD billion)
Asia-Pacific Biosimilar Testing and Development Services Market, By Country, 2019-2027 (USD billion)
China Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
China Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
China Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
China Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Japan Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Japan Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Japan Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Japan Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
India Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
India Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
India Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
India Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Southeast Asia Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Southeast Asia Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Southeast Asia Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Southeast Asia Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Australia & New Zealand Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Australia & New Zealand Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Australia & New Zealand Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Australia & New Zealand Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Rest of Asia-Pacific Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Rest of Asia-Pacific Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Rest of Asia-Pacific Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Rest of Asia-Pacific Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
09

Middle East & Africa

Based on the Middle East & Africa, the Biosimilar Testing and Development Services Market analysis covers Middle East, Africa, Rest of Middle East & Africa.

Middle East & Africa Map
Middle East & Africa Biosimilar Testing and Development Services Market Size, 2019-2027 (Us$ Mn)
Middle East & Africa Biosimilar Testing and Development Services Size, 2019-2027 (Us$ Mn)
Middle East & Africa Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Middle East & Africa Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Middle East & Africa Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Middle East & Africa Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Middle East Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Middle East Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Middle East Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Middle East Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Africa Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Africa Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Africa Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Africa Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Rest of Middle East & Africa Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Rest of Middle East & Africa Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Rest of Middle East & Africa Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Rest of Middle East & Africa Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
10

Latin America

  • In 2021, Latin America segment accounted for US$21.10 Bn and is expected grow with a CAGR of 17.21% over the forecast years.
  • In Latin America, Brazil accounted for US$9.18 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Argentina accounted for US$6.96 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Mexico accounted for US$2.42 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Colombia accounted for US$1.48 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
  • Rest of Latin America accounted for US$1.05 Bn in year 2021 and is expected to reach US$XX Bn in year 2027.
Latin America Biosimilar Testing and Development Services Market, By Country, 2019-2027 (USD billion)
Latin America Biosimilar Testing and Development Services Market, By Country, 2019-2027 (USD billion)
Latin America Biosimilar Testing and Development Services Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Latin America Biosimilar Testing and Development Services Market - Market Opportunity (USD billion), 2019, 2021 & 2027
Revenue Share (%), By Clinical Assays - Latin America (2021)
Revenue Share (%), By Clinical Assays - Latin America (2021)
Revenue Share (%), By Comparability Testing - Latin America (2021)
Revenue Share (%), By Comparability Testing - Latin America (2021)
Revenue Share (%), By Region - Latin America (2021)
Revenue Share (%), By Region - Latin America (2021)
Latin America Biosimilar Testing and Development Services Market, By Country, 2019-2027 (USD billion)
Latin America Biosimilar Testing and Development Services Market, By Country, 2019-2027 (USD billion)
Brazil Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Brazil Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Brazil Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Brazil Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Argentina Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Argentina Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Argentina Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Argentina Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Mexico Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Mexico Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Mexico Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Mexico Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Colombia Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Colombia Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Colombia Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Colombia Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Rest of Latin America Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Rest of Latin America Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Clinical Assays, 2019-2027
Rest of Latin America Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
Rest of Latin America Biosimilar Testing and Development Services Market - Historical, Forecast Market Sizes (US$ MN), By Comparability Testing, 2019-2027
11

Company Analysis

  • EUROFINS SCIENTIFIC
  • SGS SA
  • CHARLES RIVER LABORATORIES INTERNATIONAL INC.
  • PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC.
  • EXOVA GROUP PLC.
  • SOURCE BIOSCIENCE PLC.
  • INTERTEK GROUP PLC.
  • MEDISTRI SA
  • PACE ANALYTICAL SERVICES INC.
  • SIGMA-ALDRICH CO. LLC